Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04743765 · ClinicalTrials.gov registry record · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
A NA study of Hip Fractures and Myocardial Injury, sponsored by Population Health Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
- 20
- Study locations
NCT04743765 is a NA study of Hip Fractures and Myocardial Injury that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 1,100 participants, above the 548-participant average among 15 other Hip Fractures trials with a reported enrollment target (101% higher). The trial reports 20 study locations across 18 states.
The verdict
NCT04743765, a NA study of Hip Fractures and Myocardial Injury, is actively recruiting participants, sponsored by Population Health Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
- 20
- Study locations
Study Summary
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
Conditions Studied
Interventions
- OTHER Accelerated medical clearance and surgery
Study Locations (20)
Maryland
- University of Maryland - Baltimore
- Sinai Hospital of Baltimore - Baltimore
Massachusetts
- Tufts Medical Center - Boston
- Lahey Hospital and Medical Center - Burlington
Arizona
- Chandler Regional Medical Center - Chandler
California
- The Regents of the University of California - Davis
Connecticut
- Yale New Haven Hospital - New Haven
Georgia
- Emory University at Grady Memorial Hospital - Atlanta
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04743765
The ClinicalTrials.gov registry entry for NCT04743765 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 548-participant average among 15 other Hip Fractures trials with a reported enrollment target (101% higher). The listed sponsor is Population Health Research Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention - of which Accelerated medical clearance and surgery is the first listed.
NCT04743765 reports 20 study locations spanning 18 distinct geographic areas - top geographies include Maryland, Massachusetts, Arizona.
Frequently Asked Questions
What is clinical trial NCT04743765 about?
NCT04743765 is a clinical study titled "HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial". The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also ass...
What is the current status of trial NCT04743765?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,100 participants. The study started on 2021-11-22. Estimated completion is 2027-05-31.
What conditions does trial NCT04743765 study?
This clinical trial studies the following conditions: Hip Fractures, Myocardial Injury.
What interventions are being tested in trial NCT04743765?
The interventions under investigation include: Accelerated medical clearance and surgery (OTHER).
Who is sponsoring clinical trial NCT04743765?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04743765 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation
RECRUITING · NA
-
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
ACTIVE NOT RECRUITING · NA
-
Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.